PARK7 Antibody (LS-B266)

貨號 Cat. No.
LS-B266
規格 Size
50 µl
品牌 Brand
LSBio

Description













































































Antibody Catalog ID: LS-B266
Antibody Validation: This antibody replaces catalog number LS-C2826. It has been validated for use in the following assays: IHC.
Antibody Target: Parkinson Disease (autosomal Recessive, Early Onset) 7 (PARK7/DJ-1)
Synonyms: PARK7, dj-1, dj-1 protein, DJ1, FLJ27376, FLJ34360, FLJ92274, park-7, park7
Host: PARK7 antibody was produced in Rabbit
Antigen Species: PARK7 antibody was raised against Human
Clonality: Polyclonal
Antigen Type: Synthetic peptide - KLH conjugated
Immunogen: PARK7 antibody was raised against synthetic peptide
Antibody Specificity: A synthetic peptide mapping to the human PARK7 (DJ-1) protein, residues 167-189.
Antigen Modification: aa167-189
Predicted Species Reactivity: Mouse, Rat
Presentation: Serum, 0.02% sodium azide.
Recommended Storage: Long term: -20°C; Short term: +4°C
Antibody Usage Summary: Immunohistochemistry: LS-B266 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D1, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B266 was determined to be 2.5 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (2.5 µg/ml), Western blot (WB) (1:500 - 1:1000) (Optimal dilution to be determined by the researcher)
Size: 50 µl
Concentration: 1 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢